Our comprehensive radiolabeled drug capabilities include on-site nuclear pharmacy services and specialized handling expertise for complete absorption, distribution, metabolism, and excretion studies.
Radiolabeled (ADME) Studies
Key Capabilities
PROTOCOL DEVELOPMENT SUPPORT with writers and scientists experienced in ADME study design and radiolabeled compound protocols
ON-SITE NUCLEAR PHARMACY led by nuclear pharmacist for preparation of sterile and non-sterile radiolabeled dosage forms
SYNTHESIS AND FORMULATION of radiolabeled drugs through dosimetry assessment
BIOANALYTICAL SERVICES specializing in radiolabeled compound analysis, metabolite identification, and mass balance assessments with streamlined operations, faster turnaround, and end-to-end quality control
DAILY SCINTILLATION COUNTING and total radiolabeled activity measurements conducted on-site
METABOLITE IDENTIFICATION AND QUANTIFICATION with specialized isolation capabilities
MICRO-RADIOTRACER COMPOUNDING available for specialized applications
EXPERT BIOLOGICAL SAMPLE COLLECTION by staff experienced in radiolabeled study requirements
FULL-TIME INVESTIGATORS providing oversight and specialized training
FULL-TIME INVESTIGATORS AND ACLS-CERTIFIED NURSING STAFF providing 24/7 medical coverage throughout study conduct
ROBUST PARTICIPANT RECRUITMENT from experienced volunteer database
ON-SITE CAP-CERTIFIED LABORATORY for rapid laboratory value turnaround
STANDARDIZED MEAL PREPARATION by registered dietitians in an on-site kitchen, ensuring consistent food intake
PAPERLESS DATA COLLECTION via ClinQuick™ for real-time monitoring
AAHRPP-ACCREDITED FACILITIES meeting nuclear medicine safety standards
PROVEN REGULATORY EXCELLENCE with positive FDA inspection history, demonstrating consistent compliance, quality standards, and inspection readiness across all study types
